Hepatocellular adenoma medical therapy: Difference between revisions
Jump to navigation
Jump to search
Nawal Muazam (talk | contribs) No edit summary |
Nawal Muazam (talk | contribs) No edit summary |
||
| Line 5: | Line 5: | ||
==Hepatocellular adenoma medical therapy== | ==Hepatocellular adenoma medical therapy== | ||
The predominant therapy for hepatocellular adenoma is surgical resection to prevent bleeding and malignant transformation. Close monitoring and imaging is required.<ref name="pmid18333188">{{cite journal| author=Barthelmes L, Tait IS| title=Liver cell adenoma and liver cell adenomatosis. | journal=HPB (Oxford) | year= 2005 | volume= 7 | issue= 3 | pages= 186-96 | pmid=18333188 | doi=10.1080/13651820510028954 | pmc=PMC2023950 | url=http://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=18333188 }} </ref> | The predominant therapy for hepatocellular adenoma is surgical resection to prevent bleeding and malignant transformation. Close monitoring and imaging is required.<ref name="pmid18333188">{{cite journal| author=Barthelmes L, Tait IS| title=Liver cell adenoma and liver cell adenomatosis. | journal=HPB (Oxford) | year= 2005 | volume= 7 | issue= 3 | pages= 186-96 | pmid=18333188 | doi=10.1080/13651820510028954 | pmc=PMC2023950 | url=http://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=18333188 }} </ref> | ||
Treatment criteria include:<ref name=age>Introduction. Hindawi(2015). http://www.hindawi.com/journals/ijh/2013/374170. Accessed on November 2, 2015</ref> | |||
* Number of lesions | |||
* Size of lesions | |||
* Presence of symptoms | |||
* Surgical risk | |||
==References== | ==References== | ||
Revision as of 21:41, 2 November 2015
|
Hepatocellular adenoma Microchapters |
|
Diagnosis |
|---|
|
Treatment |
|
Case Studies |
|
Hepatocellular adenoma medical therapy On the Web |
|
American Roentgen Ray Society Images of Hepatocellular adenoma medical therapy |
|
Risk calculators and risk factors for Hepatocellular adenoma medical therapy |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Nawal Muazam M.D.[2]
Overview
Hepatocellular adenoma medical therapy
The predominant therapy for hepatocellular adenoma is surgical resection to prevent bleeding and malignant transformation. Close monitoring and imaging is required.[1] Treatment criteria include:[2]
- Number of lesions
- Size of lesions
- Presence of symptoms
- Surgical risk
References
- ↑ Barthelmes L, Tait IS (2005). "Liver cell adenoma and liver cell adenomatosis". HPB (Oxford). 7 (3): 186–96. doi:10.1080/13651820510028954. PMC 2023950. PMID 18333188.
- ↑ Introduction. Hindawi(2015). http://www.hindawi.com/journals/ijh/2013/374170. Accessed on November 2, 2015